Selling a put does not give an investor access to PLSE's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $10 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Pulse Biosciences Inc sees its shares decline 42.5% and the contract is exercised (resulting in a cost basis of $9.20 per share before broker commissions, subtracting the 80 cents from $10), the only upside to the put seller is from collecting that premium for the 12.9% annualized rate of return.
Below is a chart showing the trailing twelve month trading history for Pulse Biosciences Inc, and highlighting in green where the $10 strike is located relative to that history:
The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the October put at the $10 strike for the 12.9% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Pulse Biosciences Inc (considering the last 250 trading day closing values as well as today's price of $17.40) to be 92%. For other put options contract ideas at the various different available expirations, visit the PLSE Stock Options page of StockOptionsChannel.com.
In mid-afternoon trading on Tuesday, the put volume among S&P 500 components was 1.49M contracts, with call volume at 1.77M, for a put:call ratio of 0.84 so far for the day, which is unusually high compared to the long-term median put:call ratio of .65. In other words, there are lots more put buyers out there in options trading so far today than would normally be seen, as compared to call buyers. Find out which 15 call and put options traders are talking about today.
Top YieldBoost Puts of the S&P 500 »
Also see:
REITs Dividend Stocks Institutional Holders of RKT
VAL market cap history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.